CenterBook Partners LP raised its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) by 239.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 419,156 shares of the company's stock after buying an additional 295,532 shares during the period.
